Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Psychotropic medication for ADHD
Autore:
Safer, DJ; Zito, JM;
Indirizzi:
Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA Johns Hopkins Univ Baltimore MD USA 21205 ychiat, Baltimore, MD 21205 USA Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA Johns Hopkins Univ Baltimore MD USA 21205 Pediat, Baltimore, MD 21205 USA Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA Univ Maryland BaltimoreMD USA 21201 , Sch Pharm, Baltimore, MD 21201 USA Univ Maryland, Sch Med, Baltimore, MD 21201 USA Univ Maryland Baltimore MD USA 21201 nd, Sch Med, Baltimore, MD 21201 USA
Titolo Testata:
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
fascicolo: 3, volume: 5, anno: 1999,
pagine: 237 - 242
SICI:
1080-4013(1999)5:3<237:PMFA>2.0.ZU;2-1
Fonte:
ISI
Lingua:
ENG
Soggetto:
ATTENTION-DEFICIT HYPERACTIVITY; COUNTY-WIDE SAMPLE; STIMULANT TREATMENT; DEFICIT/HYPERACTIVITY DISORDER; INATTENTIVE STUDENTS; DIAGNOSTIC-CRITERIA; CHILDREN; METHYLPHENIDATE; PREVALENCE; MANAGEMENT;
Keywords:
attention deficit hyperactivity disorder; methylphenidate; pharmacoepidemiology;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
71
Recensione:
Indirizzi per estratti:
Indirizzo: Safer, DJ 7702 Dunmanway, Dundalk, MD 21222 USA 7702 Dunmanway Dundalk MDUSA 21222 nway, Dundalk, MD 21222 USA
Citazione:
D.J. Safer e J.M. Zito, "Psychotropic medication for ADHD", MENT RET D, 5(3), 1999, pp. 237-242

Abstract

Psychotropic medication treatment of attention deficit hyperactivity disorder (ADHD) has prominently increased over the last three decades such that an estimated 2 to 2.5 million youths in the United States now receive this treatment. Stimulants have been and remain the primary prescribed medication group to treat this disorder, even though the variety of medication treatments has expanded in recent years. The major reasons for the increased prevalence of stimulant treatment are: increases in the diagnostic pool-particularly the inclusion of more youths with predominantly inattentive ADHD; the great number of girls receiving this medication; increases in the duration of treatment; and a greater public acceptance of the psychopharmacologic treatment of youth. Demographic factors, school placement, geographic location, service system differences, and the specialty of the treating physician all influence the prevalence of medication treatment, and the impact of these factors will be described. Briefly reviewed at the conclusion are the use of non-stimulant medication treatments, multiple and concomitant medication treatments for ADHD, and international differences in prescribing patterns. (C) 1999 Wiley-Liss. Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/20 alle ore 21:08:47